We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+7.32%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$4.54B
AUM Growth
+$237M
Cap. Flow
-$26.5M
Cap. Flow %
-0.58%
Top 10 Hldgs %
16.93%
Holding
607
New
39
Increased
188
Reduced
275
Closed
42

Top Sells

Rank Stock Value
1
NWL icon
Newell Brands
NWL
+$16M
2
AGN
Allergan plc
AGN
+$15.1M
3
BFH icon
Bread Financial
BFH
+$14.7M
4
TECH icon
Bio-Techne
TECH
+$14M
5
DIS icon
Walt Disney
DIS
+$11.7M

Sector Composition

Rank Sector Weight
1 Healthcare 17.45%
2 Industrials 16.76%
3 Financials 14.5%
4 Technology 13.57%
5 Consumer Discretionary 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EL icon
26
Estee Lauder
EL
$29B
$45.6M 1%
358,363
-45,123
-11% -$5.42M
TECH icon
27
Bio-Techne
TECH
$11.2B
$44.9M 0.99%
1,387,460
-441,408
-24% -$14M
HCSG icon
28
Healthcare Services Group
HCSG
$1.56B
$41.5M 0.91%
786,691
+294,125
+60% +$15.4M
ARMK icon
29
Aramark
ARMK
$15B
$41.4M 0.91%
1,341,132
-31,820
-2% -$973K
FNB icon
30
FNB Corp
FNB
$6.78B
$39.9M 0.88%
2,890,553
-14,245
-0.5% -$196K
CXO
31
DELISTED
CONCHO RESOURCES INC.
CXO
$38.4M 0.85%
255,762
+97,865
+62% +$13.6M
OFIX icon
32
Orthofix Medical
OFIX
$455M
$37.2M 0.82%
680,882
-129,177
-16% -$6.7M
SBUX icon
33
Starbucks
SBUX
$118B
$35.1M 0.77%
611,012
-12,290
-2% -$696K
AVY icon
34
Avery Dennison
AVY
$12.3B
$34.7M 0.76%
301,782
-2,623
-0.9% -$284K
TMO icon
35
Thermo Fisher Scientific
TMO
$211B
$34.6M 0.76%
182,225
+34,763
+24% +$6.66M
SPXC icon
36
SPX Corp
SPXC
$11B
$34.3M 0.75%
1,092,056
+86,615
+9% +$2.63M
RTN
37
DELISTED
Raytheon Company
RTN
$33.3M 0.73%
177,048
-3,991
-2% -$744K
SLB icon
38
SLB Ltd
SLB
$77.8B
$33.2M 0.73%
492,480
-14,026
-3% -$909K
MMM icon
39
3M
MMM
$89B
$31.6M 0.7%
160,480
-2,653
-2% -$510K
DHR icon
40
Danaher
DHR
$135B
$31.2M 0.69%
379,411
-5,283
-1% -$430K
PEP icon
41
PepsiCo
PEP
$186B
$31.2M 0.69%
259,954
+362
+0.1% +$41.3K
BCPC
42
Balchem Corp
BCPC
$5.23B
$30.6M 0.67%
379,402
-10,337
-3% -$861K
AIG icon
43
American International
AIG
$41.9B
$30.6M 0.67%
513,148
+23,109
+5% +$1.42M
NTRS icon
44
Northern Trust
NTRS
$22.2B
$30M 0.66%
300,534
-46,329
-13% -$4.41M
UMPQ
45
DELISTED
Umpqua Holdings Corp
UMPQ
$29M 0.64%
1,395,632
+31,647
+2% +$654K
THS
46
DELISTED
Treehouse Foods
THS
$28.3M 0.62%
572,466
-134,288
-19% -$7.19M
APH icon
47
Amphenol
APH
$188B
$27.5M 0.61%
1,253,712
-28,576
-2% -$629K
BMS
48
DELISTED
Bemis
BMS
$27.5M 0.61%
575,520
+167,370
+41% +$7.74M
BAX icon
49
Baxter International
BAX
$11.6B
$27.2M 0.6%
421,520
+9,466
+2% +$608K
PFE icon
50
Pfizer
PFE
$140B
$26.7M 0.59%
777,074
-3,226
-0.4% -$110K

Similar funds

Segall Bryant & Hamill's Q4 2017 Portfolio in Review

As of Q4 2017, Segall Bryant & Hamill held 607 positions worth $4.54B, up 5.5% from $4.31B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Segall Bryant & Hamill's Q4 2017 filing shows 39 new, 188 increased, 275 reduced and 42 closed positions. Its largest new stake was Black Knight, Inc. Common Stock: 320,006 shares worth $14.1M. The largest sale was Newell Brands, an estimated $16M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.

  • Segall Bryant & Hamill's largest Q4 2017 buy was Black Knight, Inc. Common Stock: 320,006 shares worth $14.1M.
  • Segall Bryant & Hamill added most to FLIR Systems, Inc. (DE) Common Stock in Q4 2017, an estimated $46.2M increase.
  • Segall Bryant & Hamill's biggest Q4 2017 reduction was Newell Brands, cutting an estimated $16M.
  • Segall Bryant & Hamill fully exited Gigamon Inc. in Q4 2017, selling an estimated $8.49M.
  • Segall Bryant & Hamill's ten largest holdings make up 17% of its $4.54B portfolio in Q4 2017.
  • Segall Bryant & Hamill opened 39 new positions and closed 42 in Q4 2017.
  • Segall Bryant & Hamill's portfolio value rose 5.5% quarter-over-quarter to $4.54B.

Based on Segall Bryant & Hamill's 13F filing for Q4 2017, filed 15 Feb 2018.